195 related articles for article (PubMed ID: 23972147)
1. DNA G-quadruplex binders: a patent review.
Yan Y; Tan J; Ou T; Huang Z; Gu L
Expert Opin Ther Pat; 2013 Nov; 23(11):1495-509. PubMed ID: 23972147
[TBL] [Abstract][Full Text] [Related]
2. Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives.
Xiong YX; Huang ZS; Tan JH
Eur J Med Chem; 2015 Jun; 97():538-51. PubMed ID: 25466923
[TBL] [Abstract][Full Text] [Related]
3. Interaction of metal complexes with G-quadruplex DNA.
Georgiades SN; Abd Karim NH; Suntharalingam K; Vilar R
Angew Chem Int Ed Engl; 2010 Jun; 49(24):4020-34. PubMed ID: 20503216
[TBL] [Abstract][Full Text] [Related]
4. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
5. Pyridyl-substituted corrole isomers: synthesis and their regulation to G-quadruplex structures.
Ma H; Zhang M; Zhang D; Huang R; Zhao Y; Yang H; Liu Y; Weng X; Zhou Y; Deng M; Xu L; Zhou X
Chem Asian J; 2010 Jan; 5(1):114-22. PubMed ID: 19937863
[TBL] [Abstract][Full Text] [Related]
6. Shooting for selective druglike G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death.
Cosconati S; Rizzo A; Trotta R; Pagano B; Iachettini S; De Tito S; Lauri I; Fotticchia I; Giustiniano M; Marinelli L; Giancola C; Novellino E; Biroccio A; Randazzo A
J Med Chem; 2012 Nov; 55(22):9785-92. PubMed ID: 23057850
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic polyoxazoles as G-quadruplex ligands.
Iida K; Nagasawa K
Chem Rec; 2013 Dec; 13(6):539-48. PubMed ID: 24347328
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting.
Romano F; Di Porzio A; Iaccarino N; Riccardi G; Di Lorenzo R; Laneri S; Pagano B; Amato J; Randazzo A
Expert Opin Ther Pat; 2023 Nov; 33(11):745-773. PubMed ID: 37855085
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
[TBL] [Abstract][Full Text] [Related]
10. Sequences in the HSP90 promoter form G-quadruplex structures with selectivity for disubstituted phenyl bis-oxazole derivatives.
Ohnmacht SA; Micco M; Petrucci V; Todd AK; Reszka AP; Gunaratnam M; Carvalho MA; Zloh M; Neidle S
Bioorg Med Chem Lett; 2012 Sep; 22(18):5930-5. PubMed ID: 22892119
[TBL] [Abstract][Full Text] [Related]
11. Tandem application of virtual screening and NMR experiments in the discovery of brand new DNA quadruplex groove binders.
Cosconati S; Marinelli L; Trotta R; Virno A; Mayol L; Novellino E; Olson AJ; Randazzo A
J Am Chem Soc; 2009 Nov; 131(45):16336-7. PubMed ID: 19856964
[TBL] [Abstract][Full Text] [Related]
12. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
Jain AK; Bhattacharya S
Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
[TBL] [Abstract][Full Text] [Related]
13. Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence.
Di Leva FS; Zizza P; Cingolani C; D'Angelo C; Pagano B; Amato J; Salvati E; Sissi C; Pinato O; Marinelli L; Cavalli A; Cosconati S; Novellino E; Randazzo A; Biroccio A
J Med Chem; 2013 Dec; 56(23):9646-54. PubMed ID: 24256368
[TBL] [Abstract][Full Text] [Related]
14. Emerging Role of G-quadruplex DNA as Target in Anticancer Therapy.
Cimino-Reale G; Zaffaroni N; Folini M
Curr Pharm Des; 2016; 22(44):6612-6624. PubMed ID: 27587203
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry of G-quadruplex DNA: formation, recognition, property, conversion, and conformation.
Yuan G; Zhang Q; Zhou J; Li H
Mass Spectrom Rev; 2011; 30(6):1121-42. PubMed ID: 21520218
[TBL] [Abstract][Full Text] [Related]
16. G-quadruplexes: targets and tools in anticancer drug design.
Düchler M
J Drug Target; 2012 Jun; 20(5):389-400. PubMed ID: 22424091
[TBL] [Abstract][Full Text] [Related]
17. Monohydrazone Based G-Quadruplex Selective Ligands Induce DNA Damage and Genome Instability in Human Cancer Cells.
Amato J; Miglietta G; Morigi R; Iaccarino N; Locatelli A; Leoni A; Novellino E; Pagano B; Capranico G; Randazzo A
J Med Chem; 2020 Mar; 63(6):3090-3103. PubMed ID: 32142285
[TBL] [Abstract][Full Text] [Related]
18. Function and targeting of G-quadruplexes.
Wong HM; Payet L; Huppert JL
Curr Opin Mol Ther; 2009 Apr; 11(2):146-55. PubMed ID: 19330720
[TBL] [Abstract][Full Text] [Related]
19. Methods for investigating G-quadruplex DNA/ligand interactions.
Murat P; Singh Y; Defrancq E
Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
[TBL] [Abstract][Full Text] [Related]
20. On the Road to Fight Cancer: The Potential of G-quadruplex Ligands as Novel Therapeutic Agents.
Alessandrini I; Recagni M; Zaffaroni N; Folini M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
